Alpha Compute Corp
ATON - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$733.84K
Close$
$0.05
83.5% downside
Current Fair Value
83.5% downsideOvervalued by 83.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $733,841.00 |
|---|---|
| Enterprise Value | $-936,159.00 |
| Earnings per Share | $-4.18 |
| Beta | 0.49 |
| Outstanding Shares | 2,508,000 |
Return
| Return on Equity | 5501.63% |
|---|---|
| Return on Assets | -304.13% |
| Return on Invested Capital | -659.38% |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | -0.29 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.87 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 31, 2026
EPS Estimate
$-0.15
Consensus analyst estimateRevenue Estimate
$7.60 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 24.44%▼ 10.13% |
|---|---|
| Total Invested | $574,094▼ 43.16% |
| Investors Holding | 16▼ 3.00% |
About Portage Biotech Inc
22 employees
CEO: Brittany Kaiser
Portage Biotech Inc. is a unique entity in the world of biotechnology, catalyzing R&D to produce more quality clinical programs and maximize potential returns.